Recently Featured
Regeneron Wins Complete Dismissal of Securities Class Action Alleging Fraud Involving Sales of Retinal Disease Drugs
Securities Litigation
September 18, 2026
TELUS International Wins Complete Dismissal of Securities Fraud Class Action
Securities Litigation
August 11, 2026
Sarah
Shin
Recently Featured
Regeneron Wins Complete Dismissal of Securities Class Action Alleging Fraud Involving Sales of Retinal Disease Drugs
Securities Litigation
September 18, 2026
TELUS International Wins Complete Dismissal of Securities Fraud Class Action
Securities Litigation
August 11, 2026